Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (359)	1/3/2000 7:28:00 PM
From: Torben Noerup Nielsen	Read Replies (1) \| Respond to of 3557

I wonder what this might do for Ligand. They've been awfully quiet about their Leptin work for a long time. But if I recall correctly, they have some rights to the promoter sequence which could allow them to come up with a treatment that does not require injections; i.e., regulate the body's production of leptin instead of injecting a supplement.... But I bought Regeneron today too just in case Axokine works better :-) Thanks, Torben